Overview: Lawsuits alleging injuries from Yaz and Yasmin were among the most common cases filed in personal injury litigation last year, according to the Institute for Safe Medication Practices (ISMP). The non-profit patient safety group indicated in their latest QuarterWatch report that combined, Yaz and Yasmin were cited in more lawsuits than nearly any other drug in 2011.
- ISMP’s latest QuarterWatch report shows that, with the exception of metoclopramide, Yaz and Yasmin were named in more lawsuits than any other drug last year; 8,354 complaints involved Yaz or Yasmin in 2011
- Bayer has settled nearly 1,800 cases alleging Yaz or Yasmin caused venous blood clots for $403.6 million
- There are approximately 12,000 Yaz, Yasmin lawsuits in the US; cases allege blood clots (DVT, pulmonary embolism), gallbladder disease
Product: Yaz, Yasmin (Drospirenone and Ethinyl Estradiol)
Manufacturer: Bayer AG
Side Effects & Complications
- Blood Clots
- Pulmonary Embolism (PE)
- Deep Vein Thrombosis (DVT)
- Gallbladder Damage
- Heart Attacks
Yaz, Yasmin Lawsuits Second-Most Common Last Year
The ISMP said that Yaz and Yasmin were among the most frequently cited drugs in defective drug lawsuits, second only to metoclopramide, a medication used to treat acid reflex disease. According to the group’s most recent QuarterWatch report, there were 8,354 lawsuits that involved Yaz or Yasmin in 2011.
In total, there are more than 12,000 lawsuits in the US alleging that Yaz or Yasmin caused serious side effects. Many of the complaints say that the oral contraceptives caused blood clots, which may manifest as deep vein thrombosis (DVT), a condition where a deep vein in the legs develops of a blood clot. When this happens, there is a chance that the clot can break away and become lodged in the lungs in a condition known as pulmonary embolism.
In May, the national law firm of Parker Waichman LLP filed two lawsuits on behalf of women who developed DVT allegedly due to using Yaz or Yasmin.
Bayer Could Pay Over $1 billion in Settlements
Bayer has paid $402.6 million to settle over 1,877 lawsuits claiming that Yaz or Yasmin caused blood clots in the veins. The company estimated that the litigation could cost $1.2 billion if it continues to settle for similar amounts. Bayer also said that it has increased its reserve funds for Yaz cases, setting aside $610.5 million.